Violation Tracker Individual Record
Company:
Alexion Pharmaceuticals Inc.
Current Parent Company:
AstraZeneca
Penalty:
$21,000,000
Year:
2020
Date:
July 2, 2020
Offense Group:
competition-related offenses
Primary Offense:
Foreign Corrupt Practices Act
Secondary Offense:
financial institution supervision failures
Violation Description:
The SEC found that two Alexion subsidiaries made payments to foreign government officials to secure favorable treatment for Alexion's drug Soliris.
Level of Government:
federal
Action Type:
agency action
Agency:
Securities and Exchange Commission
Civil or Criminal Case:
civil
HQ Country of Parent:
United Kingdom
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
